Ocular Therapeutix (OCUL) Gains Following Updated on DEXTENZA NDA; FDA Says Corrective Action Address Most Issues Raised
Tweet Send to a Friend
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is up 25% in pre-open trade after the company provided an update on the status ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
